SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $10.81 million. The enterprise value is $5.88 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 8.72 million shares outstanding. The number of shares has increased by 271.34% in one year.
| Current Share Class | 8.72M |
| Shares Outstanding | 8.72M |
| Shares Change (YoY) | +271.34% |
| Shares Change (QoQ) | +75.16% |
| Owned by Insiders (%) | 1.49% |
| Owned by Institutions (%) | 3.39% |
| Float | 8.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.14 |
| Forward PS | 10.71 |
| PB Ratio | 20.32 |
| P/TBV Ratio | 19.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.64.
| Current Ratio | 0.96 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -158.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -144.37% |
| Return on Invested Capital (ROIC) | -4,324.71% |
| Return on Capital Employed (ROCE) | -3,135.22% |
| Revenue Per Employee | $22,526 |
| Profits Per Employee | -$837,105 |
| Employee Count | 19 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ICU has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.20% in the last 52 weeks. The beta is -0.87, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -0.87 |
| 52-Week Price Change | -87.20% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 2.97 |
| Relative Strength Index (RSI) | 37.66 |
| Average Volume (20 Days) | 121,103 |
Short Selling Information
The latest short interest is 282,268, so 3.24% of the outstanding shares have been sold short.
| Short Interest | 282,268 |
| Short Previous Month | 437,149 |
| Short % of Shares Out | 3.24% |
| Short % of Float | 3.29% |
| Short Ratio (days to cover) | 1.71 |
Income Statement
In the last 12 months, ICU had revenue of $428,000 and -$15.91 million in losses. Loss per share was -$3.05.
| Revenue | 428,000 |
| Gross Profit | 428,000 |
| Operating Income | -17.71M |
| Pretax Income | -33.67M |
| Net Income | -15.91M |
| EBITDA | n/a |
| EBIT | -17.71M |
| Loss Per Share | -$3.05 |
Full Income StatementBalance Sheet
The company has $5.30 million in cash and $363,000 in debt, giving a net cash position of $4.93 million or $0.57 per share.
| Cash & Cash Equivalents | 5.30M |
| Total Debt | 363,000 |
| Net Cash | 4.93M |
| Net Cash Per Share | $0.57 |
| Equity (Book Value) | 565,000 |
| Book Value Per Share | 0.06 |
| Working Capital | -248,000 |
Full Balance SheetCash Flow
| Operating Cash Flow | -15.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -4,138.79% |
| Pretax Margin | -3,714.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |